Fibrinolysis inhibitors adversely affect remodeling of tissues sealed with fibrin glue

Biomaterials

Volumn 24, Issue 2, 2003, Pages 321-327

  Krishnan, Lissy K ^a   Vijayan Lal, Arthur ^a   Uma Shankar, P R ^a   Mohanty, Mira ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

Fibrin glue; Fibrinolysis; Inhibitors; Tissue remodeling; Wound healing

Indexed keywords

AMINO ACIDS; GLUES; GRAFTS; SKIN; TISSUE;

WOUND HEALING;

PROTEINS;

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; APROTININ; FIBRIN GLUE; PLASMINOGEN ACTIVATOR INHIBITOR; TISSUE ADHESIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL REGENERATION; CONTROLLED STUDY; CRANIOTOMY; DURA MATER; LIVER; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; RABBIT; RAT; SKIN; WOUND HEALING; DRUG EFFECT; FIBRINOLYSIS;

ORYCTOLAGUS CUNICULUS;

6-AMINOCAPROIC ACID; APROTININ; FIBRIN TISSUE ADHESIVE; FIBRINOLYSIS; TISSUE ADHESIVES;

EID: 0037209951     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(02)00322-8     Document Type: Article

References (25)

1. Clark R.A.F., Lanigan J.M., DellaPelle P., Manseau E., Dvorak H.F., Clovin R.B. Fibronectin and fibrin provide aprovisional matrix forepidermal cell migration during wound reepithelialisation. J Invest Derm. 34:1992;11-16.
2. Ciano P.S., Colvin R.B., Dvorak A.M., McDonagh J., Dvorak H.F. Macrophage migration in fibrin gel matrices. Lab Invest. 54:1986;62-70.
3. Lanir N., Ciano P.S., van de Water L., McDonagh J., Dvorak A.M., Dvorak H.F. Macrophage migration in fibrin gel matrices II. Effects of clotting factor XIII, fibronectin, and glycosaminoglycan content on cell migration. J Immunol. 140:1988;2340-2349.
4. Grinnell F., Feld M., Minter D. Fibroblast adhesion to fibrinogen and fibrin substrata. requirement for cold-insoluble globulin (plasma fibronectin) Cell. 19:1980;517-525.
5. Knox P., Crooks S., Rimmer C.S. Role of fibronectin in the migration of fibroblasts into plasma clots. J Cell Biol. 102:1986;2318-2323.
6. Brown L.F., Lanir N., McDonagh J., Tognazzi K., Dvorak A.M., Dvorak H.F. Fibroblast migration in fibrin gel matrices. Am J Pathol. 142:1993;273-283.
7. Dinges H.P., Redl H., Thurnher M., Schiesser A., Schlag G. Morphometric studies on wound healing after systemic administration of adriamycin and local application of fibrin sealant. Pathol Res Pract. 181:1986;746-754.
8. Branstedt S., Rank F., Olson P.S. Wound healing and formation of granulation tissue in normal and defibrinogenated rabbits. An experimental model and histological study. Eur Surg Res. 12:1980;12-21.
9. Holand B., Junker P., Garbasch C., Christoffersen P., Lorenzen I. Formation of granulation tissue is subcutaneously implanted sponges in rats. Acta Pathol Microbiol Scand. 87(Sect. A):1979;367-374.
10. Schlag G., Redl H., Turnher M., Dinges H.P. The importance of fibrin in wound repair. Schlag G., Rdedl H. Fibrin sealant in operative medicine. Vol. 1:1986;Springer, Otolaryngology. Heidelberg.
11. Collen D., Lijnen H.R. Basic and clinical aspects of fibrinolysis and thrombolysis. Blood. 78:1991;3114-3124.
12. Vassallli J.D., Sappino A.P., Berlin D. The plasminogen activator/plasmin system. J Clin Invest. 88:1991;1067-1072.
13. Lijnen H.R., Collen D. Interaction of plasminogen activators and inhibitors with plasminogen and fibrin. Sem Thromb Hemostasis. 8:1982;2-10.
14. Redl H, Schlag G, Dinges H, Kuderna H, Seelich T. Background and methods of fibrin sealing. In: Griffin GD, Gibbons JD, Plenk H, editors. Biomaterials. New York: Wiley, 1982.
15. Grosse H., Lobbes W., Frambach M., von Broen O., Ringe B., Barthels M. The use of high dose aprotinin in liver transplantation. the influence on fibrinolysis and blood loss Thromb Res. 63:1991;287-297.
16. Griffin J.D., Ellman L. Epsilon-aminocaproic acid (EACA). Sem Thromb Hemostasis. 5:1978;27-40.
17. Booth NA. Natural inhibitors of fibrinolysis, In: Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD, editors. Haemostasis and thrombosis, 3rd ed. NewYork: Churchill Livingstone, 1994. p. 699-717.
18. Salonen E-.M., Vaheri A., Pollanen J., Stephens R., Andreasen P., Mayer M., Dano K., Gailit J., Ruoslahti E. Interaction of plasminogen activator inhibitor (PAI-1) with vitronectin. J Biol Chem. 264:1989;6339-6343.
19. Ritchie H., Robbie L.A., Kinghorn S., Exley R., Booth N.A. Monocyte plasminogen activator inhibitor 2 (PAI-2) inhibits u-PA-mediated fibrin clot lysis and is cross linked to fibrin. Thromb Hemostasis. 81:1999;96-103.
20. Mosnier L.O., Kr.von dem Borne P.A., Meijers J.C.M., Bouma B.N. Plasma TAFI Levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation. Thromb Haemostasis. 80:1998;829-835.
21. Holand B.P., Junker C., Garbasch P.C., Lorenzen I. Formation of granulation tissue in subcutaneously implanted sponges in rats. Acta Pathol Microbiol Scand. 87(Sect. A):1979;367-374.
22. Schlag G, Redl H, Turner M, Dinges HP. 1988. The importance of fibrin in wound repair in fibrin sealant in operative medicine. In: Schlag G, Redl H, editors. Otolaryngology, vol II. Heidelberg: Springer, 1988.
23. Grotendorst G.R., Martin G.R. Cell movements in wound healing and fibrosis. Rheumatology. 10:1986;385-405.
24. Bendeck M.P., Zempo N., Clowes A.W., Galardy R.E., Reidy M.A. Smooth cell migration and matrix metalloproteinase expression after arterial injury in the rat. Cir Res. 75:1994;539-545.
25. Hunt T.K., Andrews W.S., Halliday B. Coagulation and macrophage stimulation of angiogenesis and wound healing. Dineen P., Hildick-Smith G. The surgical wound. 1981;1-18 Lea & Febiger, Philadelphia.